Where Will Viking Therapeutics Be in 3 Years?

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.The pharmaceutical and biotechnology business tends to be about hitting home runs more than just getting on base. A highly successful drug, sometimes referred to as a blockbuster, can build up a small developer into a mainstream competitor. That's what investors are hoping for from Viking Therapeutics (VKTX -0.66%), a young company seeking to establish itse ...